Zoekresultaten voor

Werkzaamheid en aanvaardbaarheid van natriumpicosulfaat/ magnesiumcitraat versus polyethyleenglycol

Efficacy and acceptability of sodium picosulphate/ magnesium citrate vs low-volume polyethylene glycol plus ascorbic acid for colon cleansing: a randomized controlled trial. Auteurs: G. Manes et al.Tijdschrift: Colorectal Disease. September 2013; 15(9): 1145-53. Aim The study compared the efficacy, safety and tolerability of a low-volume picosulphate/magnesium citrate preparation with that of polyethylene glycol plus ascorbic … Continued

Eenmaal versus tweemaal daags mesalazine met verlengde afgifte voor actieve colitis ulcerosa

Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis. Auteurs: B. Flourié et al.Tijdschrift: JAlimentary Pharmacology & Therapeutics. April 2013, 37(8):767-75 Background Aminosalicylates are first-choice treatment for mild-to-moderately active ulcerative colitis (UC); however, multi-dosing regimens are inconvenient. Aim To compare the efficacy and safety of once- (OD) vs. twice- (BD) daily prolonged-release … Continued

Een gevalideerde vragenlijst over de verdraagbaarheid van de darmvoorbereiding

A validated bowel-preparation tolerability questionnaire and assessment of three commonly used bowel-cleansing agents. Auteurs: I. Lawrance et al.Tijdschrift: Digestive Diseases and Sciences. April 2013; 58(4): 926-35 Background Bowel-cleansing studies are frequently underpowered, poorly designed, and with subjective assessments. Consensus on tolerability of the bowel-cleansing agents is thus lacking. This study developed and validated a bowel-preparation … Continued

Een dubbelwerkende darmreiniger met een laag volume toegediend op de dag vóór colonoscopie

A dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study. Auteurs: P.O. Katz et al.Tijdschrift: American Journal of Gastroenterology. Maart 2013; 108(3): 401-9 Objective Optimal bowel preparation is vital for the efficacy and safety of colonoscopy. The inconvenience, discomfort, required consumption of large volumes of product, and potential … Continued

Ernstige gebeurtenissen bij darmvoorbereidingen ouderen voor poliklinische colonoscopie

Serious events in older Ontario residents receiving bowel preparations for outpatient colonoscopy with various comorbidity profiles: a descriptive, population-based study. Auteurs: J. Man-Wai Ho et al.Tijdschrift: Canadian Journal of Gastroenterology and Hepatology. Juli 2012; 26(7): 436-40 Background Polyethylene glycol-based bowel preparations (PEGBPs) and sodium picosulfate (NaPS) are commonly used for bowel cleansing before colonoscopy. Little … Continued

Mesalamine eenmaal daags is effectiever dan tweemaal daags bij patiënten met latente colitis ulcerosa

Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis. Auteurs: A. Dignass et al.Tijdschrift: Clinical Gastroenterology and Hepatology. Juli 2009; 7(7):762-9 Background Oral mesalamine (5-aminosalicylate) is the current standard of care for mild-to-moderate ulcerative colitis. We investigated the efficacy and safety of once daily administration of prolonged-release mesalamine granules … Continued

Gastro-intestinale verspreiding van orale mesalazine microgranules met verlengde afgifte (Pentasa)

Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet. Auteurs: I. Wilding et al.Tijdschrift: Alimentary Pharmacology & Therapeutics. Februari 2000; 14(2):163-9. Background There is increasing interest in using higher dosages of mesalazine for the treatment of inflammatory bowel disease; however, with current mesalazine products this involves the use of 8-16 … Continued

Werkzaamheid en tolerantie van 5-ASA-zetpillen bij de behandeling van actieve cryptogene proctitis

Comparative, open, randomized trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis: French Pentasa Study Group. Auteurs: P. Marteau et al.Tijdschrift: American Journal of Gastroenterology. Januari 2000; 95(1): 166-70 Background The efficacy and tolerance of slow-release 5-ASA suppositories (Pentasa … Continued

Dosisbereikstudie van mesalamine (PENTASA) klysma bij de behandeling van acute ulceratieve proctosigmoiditis

Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group. Auteurs: S. HanauerTijdschrift: Inflammatory Bowel Diseases. Mei 1998; 4(2):79-83 Background The safety and efficacy of mesalamine enemas were determined ina dose-ranging study enrolling 287 patients with ulcerative proctitis and proctosigmoiditis … Continued